I said earlier that I doubted an acquisition could lead to oppies being in the money, but I may have to retract that. This appears to be a good deal, and although cashflow would only build up slowly, it appears that it would provide good long term cashflow, increasing over time.
If they can get funding based on proven undeveloped rerserves, and therefore no dilution, that would be significant, as that would indicate the funders faith in potential reserves.
- Forums
- ASX - By Stock
- its good
EMR
emerald resources nl
Add to My Watchlist
0.50%
!
$3.96

I said earlier that I doubted an acquisition could lead to...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$3.96 |
Change
-0.020(0.50%) |
Mkt cap ! $2.604B |
Open | High | Low | Value | Volume |
$4.00 | $4.04 | $3.94 | $7.670M | 1.934M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | $3.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.97 | 5225 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 254 | 3.930 |
1 | 2525 | 3.920 |
2 | 1950 | 3.910 |
1 | 12668 | 3.900 |
1 | 2570 | 3.890 |
Price($) | Vol. | No. |
---|---|---|
4.200 | 134 | 1 |
4.220 | 2300 | 1 |
4.240 | 780 | 1 |
4.250 | 20110 | 2 |
4.390 | 2083 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
EMR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online